184 related articles for article (PubMed ID: 38374230)
1. SLC15A3 plays a crucial role in pulmonary fibrosis by regulating macrophage oxidative stress.
Luo J; Li P; Dong M; Zhang Y; Lu S; Chen M; Zhou H; Lin N; Jiang H; Wang Y
Cell Death Differ; 2024 Apr; 31(4):417-430. PubMed ID: 38374230
[TBL] [Abstract][Full Text] [Related]
2. Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium.
Liu Y; Lu F; Kang L; Wang Z; Wang Y
BMC Pulm Med; 2017 Apr; 17(1):63. PubMed ID: 28420366
[TBL] [Abstract][Full Text] [Related]
3. Intermittent hypoxia increases ROS/HIF-1α 'related oxidative stress and inflammation and worsens bleomycin-induced pulmonary fibrosis in adult male C57BL/6J mice.
Xiong M; Zhao Y; Mo H; Yang H; Yue F; Hu K
Int Immunopharmacol; 2021 Nov; 100():108165. PubMed ID: 34560512
[TBL] [Abstract][Full Text] [Related]
4. Suppression of nuclear factor erythroid 2-related factor 2 via extracellular signal-regulated kinase contributes to bleomycin-induced oxidative stress and fibrogenesis.
Liu R; Chen H; Bai H; Zhang W; Wang X; Qin X; Zhang X; Li W; Liang X; Hai C
Toxicol Lett; 2013 Jun; 220(1):15-25. PubMed ID: 23570914
[TBL] [Abstract][Full Text] [Related]
5. Sulforaphane prevents bleomycin‑induced pulmonary fibrosis in mice by inhibiting oxidative stress via nuclear factor erythroid 2‑related factor‑2 activation.
Yan B; Ma Z; Shi S; Hu Y; Ma T; Rong G; Yang J
Mol Med Rep; 2017 Jun; 15(6):4005-4014. PubMed ID: 28487960
[TBL] [Abstract][Full Text] [Related]
6. IL20Rb aggravates pulmonary fibrosis through enhancing bone marrow derived profibrotic macrophage activation.
Zhu J; Jiang Q; Gao S; Xia Q; Zhang H; Liu B; Zhao R; Jiang H; Li X; Xu A; Zhou H; Xu Z; Yang C
Pharmacol Res; 2024 May; 203():107178. PubMed ID: 38583686
[TBL] [Abstract][Full Text] [Related]
7. Effect of an immunotoxin to folate receptor beta on bleomycin-induced experimental pulmonary fibrosis.
Nagai T; Tanaka M; Hasui K; Shirahama H; Kitajima S; Yonezawa S; Xu B; Matsuyama T
Clin Exp Immunol; 2010 Aug; 161(2):348-56. PubMed ID: 20550546
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.
Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G
Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of TIM-3 in Macrophages Aggravates Pathogenesis of Pulmonary Fibrosis in Mice.
Wang Y; Kuai Q; Gao F; Wang Y; He M; Zhou H; Han G; Jiang X; Ren S; Yu Q
Am J Respir Cell Mol Biol; 2019 Dec; 61(6):727-736. PubMed ID: 31162951
[TBL] [Abstract][Full Text] [Related]
10. Atractylenolide III attenuates bleomycin-induced experimental pulmonary fibrosis and oxidative stress in rat model via Nrf2/NQO1/HO-1 pathway activation.
Huai B; Ding J
Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):436-444. PubMed ID: 32762376
[TBL] [Abstract][Full Text] [Related]
11. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway.
Zhu L; Fu X; Chen X; Han X; Dong P
Cell Biol Int; 2017 Sep; 41(9):960-968. PubMed ID: 28493530
[TBL] [Abstract][Full Text] [Related]
12. Liproxstatin-1 alleviates bleomycin-induced alveolar epithelial cells injury and mice pulmonary fibrosis via attenuating inflammation, reshaping redox equilibrium, and suppressing ROS/p53/α-SMA pathway.
Tao N; Li K; Liu J; Fan G; Sun T
Biochem Biophys Res Commun; 2021 Apr; 551():133-139. PubMed ID: 33735625
[TBL] [Abstract][Full Text] [Related]
13. Involvement of necroptotic cell death in macrophages in progression of bleomycin and LPS-induced acute exacerbation of idiopathic pulmonary fibrosis.
Koike A; Hayashi K; Fujimori K
Eur J Pharmacol; 2024 Jun; 972():176572. PubMed ID: 38614381
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.
Redente EF; Keith RC; Janssen W; Henson PM; Ortiz LA; Downey GP; Bratton DL; Riches DW
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):825-37. PubMed ID: 24325577
[TBL] [Abstract][Full Text] [Related]
15. The circadian clock regulates rhythmic activation of the NRF2/glutathione-mediated antioxidant defense pathway to modulate pulmonary fibrosis.
Pekovic-Vaughan V; Gibbs J; Yoshitane H; Yang N; Pathiranage D; Guo B; Sagami A; Taguchi K; Bechtold D; Loudon A; Yamamoto M; Chan J; van der Horst GT; Fukada Y; Meng QJ
Genes Dev; 2014 Mar; 28(6):548-60. PubMed ID: 24637114
[TBL] [Abstract][Full Text] [Related]
16. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
[TBL] [Abstract][Full Text] [Related]
17.
Fu J; Lu L; Wang H; Hou Y; Dou H
Int J Med Sci; 2021; 18(8):1810-1823. PubMed ID: 33746598
[No Abstract] [Full Text] [Related]
18. Protective effect of dimethyl itaconate against fibroblast-myofibroblast differentiation during pulmonary fibrosis by inhibiting TXNIP.
Han YY; Gu X; Yang CY; Ji HM; Lan YJ; Bi YQ; Si R; Qu J; Cheng MH; Gao J
J Cell Physiol; 2021 Nov; 236(11):7734-7744. PubMed ID: 34061990
[TBL] [Abstract][Full Text] [Related]
19. Suppressing Sart1 to modulate macrophage polarization by siRNA-loaded liposomes: a promising therapeutic strategy for pulmonary fibrosis.
Pan T; Zhou Q; Miao K; Zhang L; Wu G; Yu J; Xu Y; Xiong W; Li Y; Wang Y
Theranostics; 2021; 11(3):1192-1206. PubMed ID: 33391530
[TBL] [Abstract][Full Text] [Related]
20. Post-translational regulation of PGC-1α modulates fibrotic repair.
Larson-Casey JL; Gu L; Davis D; Cai GQ; Ding Q; He C; Carter AB
FASEB J; 2021 Jun; 35(6):e21675. PubMed ID: 34038004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
